CHICAGO — Patients undergoing primary reverse shoulder arthroplasty (RSA) for their glenohumeral osteoarthritis (OA) had more complications of care and higher hospital costs when they also had a diagnosis of depression, new data show.
The abstract was presented Thursday at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting.
Dr Keith Diamond
Researchers, led by Keith Diamond, MD, an orthopedic surgeon at Maimonides Medical Center in Brooklyn, New York, queried a private payer database looking for patients who had primary RSA for treatment of glenohumeral OA and also had a diagnosis of depressive disorder (DD) from 2010 through 2019. Patients without DD served as the controls.
After the randomized matching with controls at a 1:5 ratio, the study consisted of 28,410 patients: 4084 in the DD group and 24,326 in the control group.
Researchers found that patients with depression had longer hospital stays (3 vs 2 days, P = .0007). They also had higher frequency and odds of developing side effects within the period of care (47.4% vs 14.7%; odds ratio [OR], 2.27; 95% CI, 2.10 - 2.45, P < .0001).
Patients with depression also had significantly higher rates of medical complications surrounding the surgery and costs were higher ($19,363 vs $17,927,
